5 Biotech Stocks to Play the Sector’s Next Big Trend: NASH

The stars are aligning for several biotech stocks. Thirty-five billion stars in fact. That huge number in dollars represents the potential annual spending needed to treat one of the biggest and growing problems facing the healthcare sector today. We’re talking about NASH. Most often occurring in obese or glucose-intolerant people, …